Prevalence of pretreatment HIV-1 resistance to integrase strand transfer inhibitors in newly diagnosed and antiretroviral therapy-naive adults in Benin, West Africa
The prevalence of pretreatment HIV-1 resistance to integrase in this study was zero. This study reinforces the World Health Organization vision of improving patient outcomes by introducing INSTIs as first-line treatment regimens.
Authors
- Halimatou Diop‐Ndiaye (ORCID: https://orcid.org/0000-0001-5885-5448)
- Edmond Tchiakpé (ORCID: https://orcid.org/0000-0003-3594-2105)
- Abou Abdallah Malick Diouara (ORCID: https://orcid.org/0000-0003-3658-6245)
- René Kpèmahouton Kêkê
- Coumba Touré‐Kâne (ORCID: https://orcid.org/0000-0003-0496-8230)
- Nicole Vidal (ORCID: https://orcid.org/0000-0001-7022-2643)
- Akadiri Yessoufou (ORCID: https://orcid.org/0000-0002-9118-1534)
Institutions
- Inserm (FR)
- Hôpital Aristide Le Dantec (SN)
- Institute of Health Research, Epidemiological Surveillance and Training (SN)
- Université d'Abomey-Calavi (BJ)
- Progamme National Contre le Tuberculose (BJ)
- Institut de Recherche pour le Développement (FR)
- Cheikh Anta Diop University (SN)
Publication Details
- Journal
- Journal of Global Antimicrobial Resistance
- Published
- 2025-11-20
- DOI
- https://doi.org/10.1016/j.jgar.2025.11.011
- Primary Topic
- HIV/AIDS drug development and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00